Liberum Capital reiterated their hold rating on shares of Spire Healthcare Group (LON:SPI) in a research report sent to investors on Thursday morning, ThisIsMoney.Co.Uk reports.
Several other research analysts have also recently issued reports on the company. Barclays dropped their price objective on BT Group from GBX 250 ($3.27) to GBX 240 ($3.14) and set an equal weight rating on the stock in a research note on Friday, May 10th. JPMorgan Chase & Co. set a €21.00 ($24.42) price objective on Signify and gave the stock a sell rating in a research note on Monday, March 25th. Peel Hunt reissued a buy rating and issued a GBX 60 ($0.78) price objective on shares of Renewi in a research note on Wednesday, July 3rd. Credit Suisse Group set a €201.00 ($233.72) price objective on Volkswagen and gave the stock a buy rating in a research note on Wednesday, March 13th. Finally, UBS Group set a $54.00 price objective on Westlake Chemical and gave the stock a sell rating in a research note on Tuesday, July 2nd. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the stock. Spire Healthcare Group has a consensus rating of Hold and an average price target of GBX 127.78 ($1.67).
SPI opened at GBX 111.60 ($1.46) on Thursday. The company has a market capitalization of $447.61 million and a PE ratio of 39.86. The company’s 50 day simple moving average is GBX 120.72. Spire Healthcare Group has a one year low of GBX 96.15 ($1.26) and a one year high of GBX 259.20 ($3.39). The company has a debt-to-equity ratio of 48.52, a quick ratio of 0.95 and a current ratio of 1.44.
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Read More: What is the price-sales ratio?
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.